Women taking lithium must decide whether to continue the medication if they conceive or plan to conceive. Little is known about the extent of prescribing of lithium during pregnancy

Cowen, PJ

Evans, SJ

McCrea, RL

Nazareth, I

Osborn, DP

Petersen, I

Pinfold, V

PLoS ONE

English

PubMed

Rachel L. McCrea

Irwin Nazareth

Stephen J. W. Evans

David P. J. Osborn

Vanessa Pinfold

Phil J. Cowen

Irene Petersen

Crossref

Lithium Prescribing during Pregnancy: A UK Primary Care Database Study

BACKGROUND: Women taking lithium must decide whether to continue the medication if they conceive or plan to conceive. Little is known about the extent of prescribing of lithium during pregnancy. AIMS: To determine: 1) the prevalence of lithium prescribing during pregnancy and 2) to assess whether pregnancy is associated with discontinuation of lithium. METHOD: First, we identified women receiving any lithium prescriptions before and during pregnancy using The Health Improvement Network (THIN) primary care database. Subsequently, we used a Kaplan-Meier plot to compare time to last prescription in women prescribed lithium continuously three months before pregnancy and a comparison group of non-pregnant women. Finally, we described the characteristics of the women prescribed lithium in pregnancy. RESULTS: Very few women were prescribed lithium during pregnancy; out of 458,761 pregnancies, we identified 47 (0.01%) in which lithium was prescribed after the 6th week of pregnancy (when the pregnancy was likely to be known). In our study of discontinuation, we found pregnant women were more likely to stop lithium than those who were not pregnant. Of the 52 women who were being continuously prescribed lithium three months before pregnancy, only 17 (33%) continued receiving prescriptions beyond the 6th week of pregnancy. However, most of these 17 women continued treatment throughout pregnancy. CONCLUSIONS: Pregnancy was strongly associated with discontinuation of lithium. Further evidence on the risks of lithium is needed so that women can weight these against the risk of a deterioration in maternal mental health

McCrea, Rachel L

Nazareth, Irwin

Evans, Stephen JW

Osborn, David PJ

Pinfold, Vanessa

Cowen, Phil J

Petersen, Irene

LSHTM Research Online

Lithium prescribing during pregnancy: a UK primary care database study.

BackgroundWomen taking lithium must decide whether to continue the medication if they conceive or plan to conceive. Little is known about the extent of prescribing of lithium during pregnancy.AimsTo determine: 1) the prevalence of lithium prescribing during pregnancy and 2) to assess whether pregnancy is associated with discontinuation of lithium.MethodFirst, we identified women receiving any lithium prescriptions before and during pregnancy using The Health Improvement Network (THIN) primary care database. Subsequently, we used a Kaplan-Meier plot to compare time to last prescription in women prescribed lithium continuously three months before pregnancy and a comparison group of non-pregnant women. Finally, we described the characteristics of the women prescribed lithium in pregnancy.ResultsVery few women were prescribed lithium during pregnancy; out of 458,761 pregnancies, we identified 47 (0.01%) in which lithium was prescribed after the 6th week of pregnancy (when the pregnancy was likely to be known). In our study of discontinuation, we found pregnant women were more likely to stop lithium than those who were not pregnant. Of the 52 women who were being continuously prescribed lithium three months before pregnancy, only 17 (33%) continued receiving prescriptions beyond the 6th week of pregnancy. However, most of these 17 women continued treatment throughout pregnancy.ConclusionsPregnancy was strongly associated with discontinuation of lithium. Further evidence on the risks of lithium is needed so that women can weight these against the risk of a deterioration in maternal mental health

Rachel L McCrea

Stephen J W Evans

David P J Osborn

Phil J Cowen

Directory of Open Access Journals

UCL Discovery

Antenatal and postnatal mental health: clinical management and service guidance [Internet].

Antiepileptic drugs during pregnancy in primary care: a UK population based study.

Ebstein’s anomaly, and other congenital heart defects. The Lancet.

Lithium and pregnancy—a cohort study on manic-depressive women. Acta Psychiatr Scand.

Lithium toxicity profile: a systematic review and meta-analysis.

Pregnancy as a major determinant for discontinuation of antidepressants.

Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation.

Lithium Prescribing during Pregnancy: A UK Primary Care Database Study

Abstract

Similar works

Full text

Available Versions

Crossref

LSHTM Research Online

Directory of Open Access Journals

UCL Discovery